RxDoctor Payments Data

Louise Ledbetter, MD

Neurology · Columbia, TNNPI 1194704411

Payments from drug & device makers

$59,069in general payments, 2019–2025

Across 1,590 payments — averaging $37.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$32K
  • UCB, Inc.$3K
  • AbbVie$2K
  • Novartis$2K
  • Biogen$1K
  • AstraZeneca$1K
  • plus $18K from 54 others

What the payments were for

  • Speaking & faculty fees$30,15951%
  • Travel & lodging$3261%
  • Food & beverage$27,80247%
  • Education$7821%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.95$31,849
UCB, Inc.110$2,511
AbbVie(2 entities)152$2,174
Novartis84$1,541
Biogen81$1,483
AstraZeneca(2 entities)51$1,203
ANI Pharmaceuticals, Inc.56$1,202
Teva Pharmaceuticals USA, Inc.58$1,176
Neurocrine Biosciences, Inc.43$936
Lilly USA, LLC60$921
Harmony Biosciences LLC30$796
Acadia Pharmaceuticals Inc56$795
SK Life Science, Inc.44$703
Pfizer55$690
Jazz Pharmaceuticals Inc.24$558
Upsher-smith Laboratories LLC36$545
Genentech USA, Inc.33$539
Supernus Pharmaceuticals, Inc.38$516
Neurelis, Inc.31$507
Grifols USA, LLC25$485
Biohaven Pharmaceutical Holding Company Ltd.16$465
Eisai Inc.33$462
TG Therapeutics, Inc.21$395
Amgen23$363
Kyowa Kirin, Inc.18$354
Lundbeck LLC20$337
Sanofi11$301
Bristol Myers Squibb18$281
Catalyst Pharmaceuticals, Inc.13$264
Avadel CNS Pharmaceuticals, LLC10$259
Avanir Pharmaceuticals, Inc.15$258
Johnson & Johnson(2 entities)15$258
Axsome Therapeutics, Inc.13$233
Argenx US, Inc.10$209
Banner Life Sciences, LLC11$207
Mallinckrodt Hospital Products Inc.8$194
CSL Behring7$185
Biohaven Pharmaceuticals, Inc.19$177
Inspire Medical Systems, Inc.6$168
Adamas Pharmaceuticals, Inc.8$146
Otsuka America Pharmaceutical, Inc.8$143
Octapharma USA, Inc.5$126
Impel Pharmaceuticals Inc.6$118
Sumitomo Pharma America, Inc.6$112
E.r. Squibb & Sons, L.L.C.6$109
Ipsen Biopharmaceuticals, Inc5$101
Currax Pharmaceuticals LLC7$100
Alnylam Pharmaceuticals Inc.5$98
Amneal Pharmaceuticals LLC6$97
Tanabe Pharma America, Inc.6$97
Arbor Pharmaceuticals, Inc.6$93
MDD US Operations, LLC4$87
Impel Pharmaceuticals LLC4$86
Mallinckrodt Enterprises LLC3$85
Novo Nordisk5$80
Sunovion Pharmaceuticals Inc.5$70
Avion Pharmaceuticals4$69
Merz Pharmaceuticals, LLC3$67
Zyla Life Sciences, Inc.5$62
Scilex Pharmaceuticals Inc.3$59

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,069 in reported general payments places this provider in the 80th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee

Medicare billing

Part B allowed, 2024
$215,822
Medicare patients
718
Services billed
3,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5034$565,824
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5037$458,197
Gamunex-CImmune Globul G/Gly/Iga Avg 4644$395,005
NuplazidPimavanserin Tartrate68$380,823
Kesimpta PenOfatumumab37$314,646
OctagamImmun Globg(Igg)/Malt/Iga Ov5021$302,283
XywavSodium,calcium,mag,pot Oxybate13$257,164
BotoxOnabotulinumtoxina133$209,722
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5013$159,030
BivigamImmun Glob G(Igg)/Gly/Iga Ov5028$117,265
AubagioTeriflunomide13$112,261
MayzentSiponimod11$100,401
Emgality PenGalcanezumab-Gnlm100$98,260
Nurtec OdtRimegepant Sulfate69$83,667
NourianzIstradefylline24$82,531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringPrivigen, Hizentra$185$641,41846 claims
PfizerOctagam, Nurtec Odt, Eliquis, Dilantin$690$407,413131 claims
Grifols USA, LLCGamunex-C$485$395,00544 claims
Acadia Pharmaceuticals IncNuplazid$795$380,82368 claims
AbbVieBotox, Ubrelvy, Qulipta$2,174$326,930227 claims
SanofiAubagio$301$112,26113 claims
NovartisMayzent$1,541$100,40111 claims
Kyowa Kirin, Inc.Nourianz$354$82,53124 claims
UCB, Inc.Neupro$2,511$37,53534 claims
SK Life Science, Inc.Xcopri$703$28,57020 claims
Ipsen Biopharmaceuticals, IncDysport$101$26,98925 claims
Amneal Pharmaceuticals LLCRytary$97$23,40348 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 361 neurology providers in Tennessee.

Other neurology in Columbia

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →